SOX11 and breast cancer: We propose that lowering Sox11 levels in mouse mammary tumour cells, particularly tumour cells that are in a hybrid epithelial/mesenchymal state, leads to a release from a non-proliferative state with an increased capacity to expand and undergo invasive growth.